Documentary film shown simultaneously in four states on Feb. 27
FOR IMMEDIATE RELEASE
Belmar Pharma Solutions
Golden, CO—Feb. 27, 2025 — Belmar Pharma Solutions, the nation’s leading compounding pharmacy organization focusing on hormone health and longevity, recently hosted a screening of “Understanding Stealth Syndromes.” The documentary explores three complex, debilitating syndromes that affect nearly every part of the body. Because they’re invisible and are not commonly known, many people who are impacted say they feel like hypochondriacs.
The film shines a light on Mast Cell Activation Syndrome (MCAS), Ehlers-Danlos Syndrome (EDS), and Postural Orthostatic Tachycardia Syndrome (POTS). Many people suffer from these multi-systemic disorders for decades, often starting in childhood.
Belmar Pharma Solutions collaborates with healthcare providers and patients facing stealth syndromes, which often necessitate multiple compounded medications due to the heightened sensitivity of people with the syndromes.
“Belmar Pharma Solutions is dedicated to partnering with providers to ensure patients with these often-overlooked, life-altering syndromes receive the care they need,” said Belmar Pharma Solutions’ Vice President of Product Management Samantha Lebsock, PharmD. “These conditions demand both compassion and awareness, and it’s essential that providers and patients know there are effective therapies available to support treatment.”
As Leonard Weinstock, MD, a leading mast cell researcher, noted, “Up to one in six people in the Northern Hemisphere has one or more of these syndromes, yet it is rare for doctors to have knowledge about them or the simple skills required to diagnose them.”
Every area of medicine encounters individuals with symptoms related to these elusive syndromes, whether they realize it or not. Once doctors become aware of this triad of stealth syndromes, they can make accurate diagnoses and often implement simple, effective treatments.
The Golden event included a live Q&A session for patients and medical professionals following the film. “Understanding Stealth Syndromes” was shown simultaneously in Belmar communities including Golden; Odessa, Florida; North Salt Lake, Utah; and Madison, Wisconsin.
The Documentary is an LDN Research Trust production. The LDN Research Trust is a nonprofit organization that aims to initiate clinical trials of Low Dose Naltrexone for autoimmune diseases and has helped more than 100,000 people obtain LDN from a general practitioner or consultant.
# # #
About Belmar Pharma Solutions
Belmar Pharma Solutions is the nation’s leading compounding pharmacy organization focusing on hormone health and longevity. Established in 1985, the company is accredited by the National Association of Boards of Pharmacy, certified by LegitScript and is a member of the Alliance for Pharmacy Compounding. Headquartered in Golden, Colorado, Belmar Pharma Solutions operates 503A compounding pharmacies in Arizona, Colorado, Florida, Kansas, Utah, and Wisconsin, and 503B FDA-registered outsourcing facilities in Colorado. Learn more at https://www.belmarpharmasolutions.com.
